Activity

Filter

Cancel
Date Panel Item Activity
13 actions
Optic Atrophy v2.0 PPIB Gene migrated from ENSG00000166794 to ENSG00000166794 (gene set migration)
Optic Atrophy v1.54 PPIB Zornitza Stark Tag founder tag was added to gene: PPIB.
Optic Atrophy v1.54 PPIB Zornitza Stark Marked gene: PPIB as ready
Optic Atrophy v1.54 PPIB Zornitza Stark Gene: ppib has been classified as Amber List (Moderate Evidence).
Optic Atrophy v1.54 PPIB Zornitza Stark Classified gene: PPIB as Amber List (moderate evidence)
Optic Atrophy v1.54 PPIB Zornitza Stark Gene: ppib has been classified as Amber List (Moderate Evidence).
Optic Atrophy v1.53 PPIB Zornitza Stark Classified gene: PPIB as Amber List (moderate evidence)
Optic Atrophy v1.53 PPIB Zornitza Stark Gene: ppib has been classified as Amber List (Moderate Evidence).
Optic Atrophy v1.52 PPIB Zornitza Stark Classified gene: PPIB as Red List (low evidence)
Optic Atrophy v1.52 PPIB Zornitza Stark Gene: ppib has been classified as Red List (Low Evidence).
Optic Atrophy v1.51 PPIB Zornitza Stark Classified gene: PPIB as Amber List (moderate evidence)
Optic Atrophy v1.51 PPIB Zornitza Stark Gene: ppib has been classified as Amber List (Moderate Evidence).
Optic Atrophy v1.50 PPIB Rylee Peters gene: PPIB was added
gene: PPIB was added to Optic Atrophy. Sources: Literature
Mode of inheritance for gene: PPIB was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: PPIB were set to 41045073
Phenotypes for gene: PPIB were set to Optic atrophy (MONDO:0003608), PPIB-related
Review for gene: PPIB was set to AMBER
Added comment: PMID: 41045073 report 19 individuals from 9 families with adult‑onset autosomal dominant optic atrophy with a recurrent p.(Arg180Trp) missense variant (present in 7 hets in gnomAD v4). Segregation testing also identified the variant in 7 unaffected individuals (6 of whom were younger than 30yo). Somalier (relatedness metric) found possible distant relationships between 3 families; and 5 families have a shared haplotype, indicating a possible founder effect. Patient-derived fibroblasts showed altered mitochondrial morphology and subtle respiratory chain defects.
Sources: Literature